Targeting IAP proteins for therapeutic intervention in cancer

S Fulda, D Vucic - Nature reviews Drug discovery, 2012 - nature.com
Evasion of apoptosis is one of the crucial acquired capabilities used by cancer cells to fend
off anticancer therapies. Inhibitor of apoptosis (IAP) proteins exert a range of biological …

Emerging insights into the molecular and cellular basis of glioblastoma

GP Dunn, ML Rinne, J Wykosky… - Genes & …, 2012 - genesdev.cshlp.org
Glioblastoma is both the most common and lethal primary malignant brain tumor. Extensive
multiplatform genomic characterization has provided a higher-resolution picture of the …

Inhibition of colony stimulating factor-1 receptor abrogates microenvironment-mediated therapeutic resistance in gliomas

D Yan, J Kowal, L Akkari, AJ Schuhmacher, JT Huse… - Oncogene, 2017 - nature.com
Glioblastomas represent the most aggressive glioma grade and are associated with a poor
patient prognosis. The current standard of care, consisting of surgery, radiation and …

Small-molecule SMAC mimetics as new cancer therapeutics

L Bai, DC Smith, S Wang - Pharmacology & therapeutics, 2014 - Elsevier
Apoptosis is a tightly regulated cellular process and faulty regulation of apoptosis is a
hallmark of human cancers. Targeting key apoptosis regulators with the goal to restore …

Pharmacological targeting of cell cycle, apoptotic and cell adhesion signaling pathways implicated in chemoresistance of cancer cells

D Alimbetov, S Askarova, B Umbayev, T Davis… - International journal of …, 2018 - mdpi.com
Chemotherapeutic drugs target a physiological differentiating feature of cancer cells as they
tend to actively proliferate more than normal cells. They have well-known side-effects …

Targeting programmed cell death using small‐molecule compounds to improve potential cancer therapy

B Ke, M Tian, J Li, B Liu, G He - Medicinal research reviews, 2016 - Wiley Online Library
Evasion of cell death is one of the hallmarks of cancer cells, beginning with long‐
established apoptosis and extending to other new forms of cell death. An elaboration of cell …

The regulatory crosstalk between kinases and proteases in cancer

C López-Otín, T Hunter - Nature Reviews Cancer, 2010 - nature.com
Kinases and proteases are responsible for two fundamental regulatory mechanisms—
phosphorylation and proteolysis—that orchestrate the rhythms of life and death in all …

Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma

N Syed, J Langer, K Janczar, P Singh, C Lo Nigro… - Cell death & …, 2013 - nature.com
Arginine deprivation, either by nutritional starvation or exposure to ADI-PEG20, induces
adaptive transcriptional upregulation of ASS1 and ASL in glioblastoma multiforme ex vivo …

Current understanding on EGFR and Wnt/β-catenin signaling in glioma and their possible crosstalk

I Paul, S Bhattacharya, A Chatterjee… - Genes & …, 2013 - journals.sagepub.com
Glioblastoma multiformes (GBMs) are extensively heterogeneous at both cellular and
molecular levels. Current therapeutic strategies include targeting of key signaling molecules …

Apoptotic signaling pathways in glioblastoma and therapeutic implications

SA Valdés-Rives, D Casique-Aguirre… - BioMed research …, 2017 - Wiley Online Library
Glioblastoma multiforme (GBM) is the most hostile type of brain cancer. Its aggressiveness is
due to increased invasion, migration, proliferation, angiogenesis, and a decreased …